Related Experiment Video
Updated: Aug 8, 2026

Inactivation of Pathogens via Visible-Light Photolysis of Riboflavin-5′-Phosphate
Published on: April 6, 2022
Effects of riboflavin in children with complex II deficiency
Marianna Bugiani1, Eleonora Lamantea, Federica Invernizzi
1Department of Child Neurology, Istituto Nazionale Neurologico C. Besta, Milano, Italy. mbugiani@istituto-besta.it
Insights
Riboflavin treatment shows promise for children with complex II deficiency, a rare mitochondrial disease. Supplementation stabilized or improved neurological conditions and reduced lactate levels in patients, suggesting a potential therapeutic approach.
Area of Science:
- Biochemistry
- Pediatric Neurology
- Mitochondrial Medicine
Background:
- Isolated complex II deficiency is a rare, progressive mitochondrial disease in children.
- Current treatments are lacking, leading to severe motor and mental deterioration.
- Mitochondrial dysfunction impacts cellular energy production and overall health.
Purpose of the Study:
- To investigate the efficacy of riboflavin as a treatment for isolated complex II deficiency.
- To assess the impact of riboflavin on neurological status and metabolic markers in affected children.
- To evaluate the effect of riboflavin on complex II activity in patient-derived cells.
Main Methods:
- Case series of three children with complex II deficiency treated with oral riboflavin.
- Longitudinal follow-up for a mean of 4.5 years, monitoring neurological and growth parameters.
- Biochemical analysis of plasma lactate levels and in vitro study of riboflavin's effect on fibroblast complex II activity.
Main Results:
- Two patients with leukoencephalopathy showed stable or improved neurological conditions.
- The third patient experienced decreased plasma lactate levels and no neurological decline.
- Riboflavin increased complex II activity in cultured patient fibroblasts, but not in controls.
Conclusions:
- Riboflavin supplementation may be a beneficial treatment for isolated complex II deficiency.
- Early intervention with riboflavin could potentially halt or reverse disease progression.
- Further research is warranted to confirm riboflavin's therapeutic role in this condition.
Abstract:
Isolated complex II deficiency is a rare cause of mitochondrial disease in infancy and childhood. No satisfactory treatment is currently available, and affected patients undergo a relentlessly progressive motor and mental deterioration. We report on three complex II-deficient children treated with riboflavin per os, who were followed-up for a mean period of 4.5 years. In two patients with early-onset leukoencephalopathy, neurological condition remained stable or even moderately improved. In the third child, presenting in the first year of life with poor somatic growth and severe hyperlactacidemia, plasma lactate decreased to near-normal levels, and he did not develop signs of neurological involvement. Riboflavin supplementation to the growth medium of cultured fibroblasts resulted in a 2-fold increase of complex II activity in patients, but not in controls.
Related Concept Videos
Inborn Errors of Metabolism
Vitamins
Role of Reduced Coenzymes NADH and FADH₂
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Electron Transport Chain: Complex III and IV

